By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



1-3 Burtonhole Lane, Mill Hill

London    NW7 1AD  United Kingdom
Phone: 44-0-20-8906-7100 Fax: n/a



Drug Discovery

Company News
Heptares Technology Enables Breakthrough In Drug Discovery Collaboration With AstraZeneca PLC (AZN) 1/22/2015 10:23:02 AM
Heptares Adds Experts In Drug Discovery And Development To Its Board Of Directors 1/8/2015 9:02:15 AM
Heptares To Present At Upcoming East/West CEO Conference 1/6/2015 1:42:14 PM
Heptares Extends Global Patent Protection For GPCR-Focused Drug Discovery Platform With Grant Of Core Patents In The United States 12/15/2014 7:34:57 AM
Heptares Orphan Disease Programme Awarded Grant From The UK Biomedical Catalyst 11/20/2014 1:14:35 PM
Heptares First-In-Class Selective Muscarinic Agonists Chosen As One Of Top Neuroscience Projects To Watch 11/17/2014 11:36:36 AM
Heptares To Present On Structure-Based Drug Design Using G Protein-Coupled Receptors At Inaugural Chemistry & Engineering News Virtual Symposium 9/16/2014 9:17:33 AM
Heptares To Present At CNS Partnering & Deal-Making And Biopharm America 9/10/2014 8:35:28 AM
Heptares Release: Innovative Technology Enables First Crystal Structure Of A Class C GPCR Drug Target (mGLU5) Transmembrane Domain To Be Determined 7/17/2014 10:30:48 AM
Heptares Announces Publication In Nature Of First Structure Of Metabotropic Glutamate Receptor 5 Transmembrane Domain 7/7/2014 9:05:47 AM